Industry reports
Editor highlights

Pharmaceutical Industry Market Research Reports in Germany, April 2014

You might be interested in: drug, clinical trial, vaccine, more »

» View Public Reports

1-35 of about 400 reports

Cough, Cold and Allergy (Hay Fever) Remedies in Germany

  • Industry report
  • August 2013
  • 3 pages

The Cough, Cold and Allergy (Hay Fever) Remedies in Germany CapsuleĀ provides headlines, market sizeĀ and competitive analysis alongside a set of charts including company shar...

  • Industries: Drug and Medication
  • Countries: Germany

Company Report: Pathology in The United States and Germany for Year 2014

  • Company report
  • March 2014
  • 21 pages

... By activaero vectura strategic priorities products focused on airways diseases balanced pipeline breadth of enabling technologies revenue-generating assets near-to-market products opportunities for self ...

  • Industries: Pathology
  • Countries: United States, World, Germany

Company Report: Pathology in Germany for Year 2014

  • Company report
  • March 2014
  • 9 pages

... Multimorbid primary care patients aged 65 to 85 years. depression was defined as a score of six points or more on the geriatric depression scale (gds-15). Subjects passed a geriatric assessment, including ...

  • Industries: Pathology
  • Countries: Germany

MorphoSys AG - Company Report for Year 2014

  • Company report
  • January 2014
  • 2 pages
  • Industries: Pathology
  • Countries: Germany

Company Report: Drug Delivery in Europe for Year 2013

  • Company report
  • December 2013
  • 3 pages

... By alimera in the eu on a country-by-country basis. About psivida corp. Psivida corp., Headquartered in watertown, ma, develops tiny, sustained release, drug delivery products designed to deliver drugs ...

  • Industries: Drug Delivery Technology
  • Countries: United Kingdom, Europe, Germany

Alimera Sciences Inc. - Investment Analysis, December 2013

  • Company report
  • December 2013
  • 6 pages
  • by Corporation
  • Industries: Pharmaceutical
  • Countries: Germany, United States, Europe

Company Report: Pharmaceutical in Europe for Year 2013

  • Company report
  • November 2013
  • 2 pages
  • Industries: Pharmaceutical
  • Countries: France, Europe, Germany

MediGene AG - Company Report for Year 2013

  • Company report
  • November 2013
  • 3 pages

... Partnership, syncore has undertaken to finance the phase iii trial in full. This trial is expected to start in the second half of 2014. Rhudex medigene plans to conduct a phase ii clinical trial in primary ...

  • Industries: Drug Discovery and Development
  • Countries: Germany, World, United States

Company Report: Glioblastoma in Germany for Year 2013

  • Company report
  • November 2013
  • 2 pages

... Ation as part of the preparations for the new glioblastoma study at the university hospital m nster and is the second after the one at the university hospital charit in berlin. Prof. Dr. Med. Walter ...

  • Industries: Pathology
  • Countries: Germany

Company Report: Prescription Drug in The United States and Germany for Year 2013

  • Company report
  • November 2013
  • 32 pages

... The sector with the highest criminality in the us, as measured by the fines levied for criminal and fraudulent activity. In both the us and germany, pricks to the prescription drugs bubble are modest ...

  • Industries: Prescription Drug
  • Countries: United States, Germany

Company Report: Pathology in The United States, Germany and Japan for Year 2013

  • Company report
  • November 2013
  • 5 pages
  • Industries: Pathology
  • Countries: United States, Germany, Japan

Company Report: Pathology for Year 2013

  • Company report
  • October 2013
  • 32 pages

... Melanoma, colorectal cancer (crc), gastric cancer, breast cancer, neuroendocrine tumor (net), hepatocellular carcinoma (hcc) and cholangiocarcinoma intend to support investigator initiated trials (iits ...

  • Industries: Pathology
  • Countries: Germany, Europe, World

Company Report: Drug Discovery and Development in Germany for Year 2013

  • Company report
  • October 2013
  • 2 pages
  • Industries: Drug Discovery and Development
  • Countries: Germany

Company Report: Pathology for Year 2013

  • Company report
  • October 2013
  • 32 pages

... Melanoma, colorectal cancer (crc), gastric cancer, breast cancer, neuroendocrine tumor (net), hepatocellular carcinoma (hcc) and cholangiocarcinoma intend to support investigator initiated trials (iits ...

  • Industries: Pathology
  • Countries: Germany, Europe, World

Company Report: Drug Discovery and Development in Germany for Year 2013

  • Company report
  • October 2013
  • 2 pages
  • Industries: Drug Discovery and Development
  • Countries: Germany

Evotec AG - Annual Report 2013

  • Company report
  • October 2013
  • 128 pages
  • Industries: Drug Discovery and Development
  • Countries: Germany, United States

Vitamin Market in The United States and Europe

  • Industry report
  • September 2013
  • 10 pages

... Network vitamin e (blood) is not a good indicator of antioxidant status carotenoids predict antioxidant status you are what you eat(and absorb) antioxidants from the foods you consume ...

  • Industries: Vitamin and Supplement
  • Countries: Germany, United States, Europe

Company Report: Clinical Trial in Europe for Year 2013

  • Company report
  • September 2013
  • 9 pages
  • Industries: Drug Discovery and Development
  • Countries: Europe, Russian Federation, Germany

PAION AG - Company Report for Year 2013

  • Company report
  • August 2013
  • 5 pages
  • Industries: Pharmaceutical
  • Countries: South Korea, Germany

Mologen AG - Investment Analysis, August 2013

  • Company report
  • August 2013
  • 3 pages
  • Industries: Pathology
  • Countries: Germany

PAION AG - Company Report for Year 2013

  • Company report
  • August 2013
  • 5 pages
  • Industries: Pharmaceutical
  • Countries: South Korea, Germany

Company Report: Pharmaceutical in The United States, China and Germany for Year 2013

  • Company report
  • August 2013
  • 4 pages
  • Industries: Pharmaceutical
  • Countries: United States, China, Germany

Company Report: Pathology in Germany and Japan for Year 2013

  • Company report
  • August 2013
  • 6 pages
  • Industries: Pathology
  • Countries: Germany, Japan

Company Report: Pathology in Germany for Year 2013

  • Company report
  • August 2013
  • 6 pages

... Amsterdam/the netherlands). After the successful completion of the phase-i part of the shore study in the treatment of colorectal cancer (crc), 4sc decided to discontinue the development of resminostat ...

  • Industries: Pathology
  • Countries: Germany

Company Report: Clinical Trial in Belgium and Germany for Year 2013

  • Company report
  • June 2013
  • 2 pages
  • Industries: Drug Discovery and Development
  • Countries: Belgium, Germany

Company Report: Drug and Medication in Sweden and Germany for Year 2013

  • Company report
  • June 2013
  • 3 pages

... Be given broader approval as the vaccine, through its use, generated more safety data. The problem with narcolepsy surrounding the swine flu vaccine pandremix may have contributed to the fda's cautious ...

  • Industries: Drug and Medication
  • Countries: Sweden, Germany

Company Report: Clinical Trial in Germany for Year 2013

  • Company report
  • June 2013
  • 8 pages

... Of this course evaluate the content and the trainer of this course as excellent (9 points on a ten-point-scale) who should attend Directors, vice-presidents project managers and clinical trial staff ...

  • Industries: Drug Discovery and Development
  • Countries: Germany

Pharmaceutical Key Market Figures in Germany

  • Industry report
  • June 2013
  • 27 pages

... Dialogues within the pharma industry germany pharmaceutical industry overview cphi, icse & p-mec china innovation and development forum main forum: policy and market june 25, 2013 ralf ...

  • Industries: Pharmaceutical
  • Countries: Germany

Company Report: Pathology in The United States and Europe for Year 2013

  • Company report
  • June 2013
  • 17 pages

... Implicated in a range of diabetic eye diseases such as diabetic macular edema. Thrombogenics will utilize eleven biotherapeutics proprietary amp-rx protein design technology to create a novel ...

  • Industries: Pathology
  • Countries: United States, Europe, Germany

The German Drug and Medication Industry

  • Industry report
  • June 2013
  • 35 pages
  • by Governmental Agency

... Concentrations: influent, effluent high amount of waste water throughput analgesics/ anti inflammatories - psychiatric drugs beta blocker hormones lipid regulators ciprofloxacin clarithromycin ...

  • Industries: Drug and Medication
  • Countries: Germany

Company Report: Therapeutics in The United States and Germany for Year 2013

  • Company report
  • June 2013
  • 17 pages

... Management reporting as reviewed by the senior management team in order to assess performance and allocate resources. The group is managed on a business segment basis rnai therapeutics and unallocated ...

  • Industries: Therapy
  • Countries: United States, Germany

» Purchase Premium Reports (From $ 125 - $ 6 995)

About 1 100 reports
PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, ...

Germany Drownings, Dalys

May 2013 $ 250

» Read our Company Profiles

1 Companies

PAION AG

Germany

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.